Genetic polymorphism in the TRAF3IP2 gene is associated with psoriasis vulgaris in a Japanese population

Journal of Dermatological Science

Volumn 73, Issue 3, 2014, Pages 264-265

  Hayashi, Mitsuha ^a   Hirota, Tomomitsu ^b   Saeki, Hidehisa ^a   Nakagawa, Hidemi ^a   Ishiuji, Yozo ^a   Matsuzaki, Hiroyuki ^a   Tsunemi, Yuichiro ^c   Kato, Toyoaki ^d   Shibata, Sayaka ^d   Sugaya, Makoto ^d   Sato, Shinichi ^d   Tada, Yayoi ^e   Doi, Satoru ^f   Miyatake, Akihiko ^g   Ebe, Kouji ^h   Noguchi, Emiko ⁱ   Ebihara, Tamotsu ^j   Amagai, Masayuki ^j   Esaki, Hitokazu ^k   Takeuchi, Satoshi ^k   Furue, Masutaka ^k   Tamari, Mayumi ^b   more..

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^g Miyatake Asthma Clinic   (Japan)

^h Takao Hospital   (Japan)

ⁱ UNIVERSITY OF TSUKUBA   (Japan)

^j KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KYUSHU UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSORIASIS; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS;

EID: 84895120109     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.11.012     Document Type: Letter

References (10)

1. Leonardi C., Matheson R., Zachariae C., Cameron G., Li L., Edson-Heredia E., et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 2012, 336:1190-1199.
2. Papp K.A., Leonardi C., Menter A., Ortonne J.-P., Krueger J.G., Kricorian G., et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med 2012, 366:1181-1189.
3. Ellinghaus E., Ellinghaus D., Stuart P.E., Nair R.P., Debrus S., Raelson J.V., et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 2010, 42:991-995.
4. Hüffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E., et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriasis arthritis and psoriasis. Nat Genet 2010, 42:996-999.
5. Koga C., Kabashima K., Shiraishi N., Kobayashi M., Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008, 128:2625-2630.
6. Matsushima Y., Kikkawa Y., Takada T., Matsuoka K., Seki Y., Yoshida H., et al. An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene. J Immunol 2010, 185:2340-2349.
7. Shimizu M., Matsuda A., Yanagisawa K., Hirota T., Ahahoshi M., Inomata N., et al. Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 2005, 14:2919-2927.
8. De{ogonek}bniak T., Soczawa E., Boer M., Różewicka-Czabańska M., Wiśniewska J., Serrano-Fernandez P., et al. Common variants of ZNF750, RPTOR and TRAF3IP2 genes and psoriasis risk. Arch Dermatol Res 2013, [in press]. 10.1007/s00403-013-1407-9.
9. Doyle M.S., Collins E.S., Fitzgerald O.M., Pennington S.R. New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis. Arthritis Res Ther 2012, 14:226.
10. Wilsmann-Theis D., Hagemann T., Jordan J., Bieber T., Novak N. Facing psoriasis and atopic dermatitis: are there more similarities or more differences?. Eur J Dermatol 2008, 18:172-180.